Related references
Note: Only part of the references are listed.c-Maf enforces cytokine production and promotes memory-like responses in mouse and human type 2 innate lymphoid cells
Sara Trabanelli et al.
EMBO JOURNAL (2022)
Nivalenol affects Cyclin B1 level and activates SAC for cell cycle progression in mouse oocyte meiosis
Ping-Shuang Lu et al.
CELL PROLIFERATION (2022)
TCR-Vγδ usage distinguishes protumor from antitumor intestinal γδ T cell subsets
Bernardo S. Reis et al.
SCIENCE (2022)
Targeting the oncogenic transcription factor c-Maf for the treatment of multiple myeloma
Qiuyun Jiang et al.
CANCER LETTERS (2022)
Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer
Jeremy Goc et al.
CELL (2021)
Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells
Maria Casanova-Acebes et al.
NATURE (2021)
Constrained TCRγδ-associated Syk activity engages PI3K to facilitate thymic development of IL-17A-secreting γδ T cells
Nital Sumaria et al.
SCIENCE SIGNALING (2021)
c-Maf regulates the plasticity of group 3 innate lymphoid cells by restraining the type 1 program
Morgan E. Parker et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Transcription factor c-Maf is a checkpoint that programs macrophages in lung cancer
Min Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lung
Martijn J. Schuijs et al.
NATURE IMMUNOLOGY (2020)
The transcription factor c-Maf is essential for the commitment of IL-17-producing γδ T cells
Matthew K. Zuberbuehler et al.
NATURE IMMUNOLOGY (2019)
γδT17 Cells Promote the Accumulation and Expansion of Myeloid-Derived Suppressor Cells in Human Colorectal Cancer
Pin Wu et al.
IMMUNITY (2014)
Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma
EM Hurt et al.
CANCER CELL (2004)